Announcements
THE ANSPACH EFFORT INC. SELECTS CLINIVATION
GLOBAL® XI.
Emerging leader in instrumentation products selects clinivation Global xi to manage its medical products approvals and submissions worldwide.
Framingham, MA, March 15, 2007
- clinivation, Inc. announced today that The Anspach Effort, Inc. has selected clinivation Global® xi Market Clearance
Management solution.
"Anspach is clearly an emerging leader in the development
of instrumentation for various medical applications, and we are
excited that Anspach's management has selected clinivation Global
xi to help impact market clearance operations to better achieve
sales and marketing objectives," said Joseph Kozikowski, M.D., clinivation's
Chief Executive Officer.
Clinivation Global xi software enables medical device companies to sell more products to more countries faster and easier than ever before. Clinivation Global xi is the first complete solution targeted at automating the business processes for market clearance operations worldwide.
About The Anspach Effort, Inc.
The Anspach Effort, Inc. is a successful, continuously evolving business whose focus concentrates on high-speed instrumentation for Neurosurgery, Neurotology, Otology, and Orthopedics. We are committed to providing product quality, technology, and service that is best in class.
For more information, visit www.anspach.com.
About clinivation, Inc.
Clinivation's business is productivity- taking the time and labor out of making better medical products.
Since 1999, our productivity software and solutions have delivered superior value to market leaders in medical devices, pharmaceuticals, and diagnostics.
Visit clinivation online at www.clinivation.com. For further information, please contact:
|
